TrueWealth LLC’s Atossa Therapeutics ATOS Stock Holding History

TrueWealth LLC’s Portfolio ATOS Stock Details ATOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	$0	Hold	3	–	–	﹤0.01%	713
2020 Q1	$0	Hold	3	–	–	﹤0.01%	721
2019 Q4	$0	Hold	3	–	–	﹤0.01%	729
2019 Q3	$0	Hold	3	–	–	﹤0.01%	696
2019 Q2	$0	Hold	3	–	–	﹤0.01%	721
2019 Q1	$0	Hold	3	–	–	﹤0.01%	725
2018 Q4	$0	Hold	3	–	–	﹤0.01%	731
2018 Q3	$0	Hold	3	–	–	﹤0.01%	820
2018 Q2	$0	Hold	3	–	–	﹤0.01%	832
2018 Q1	$0	Hold	3	–	–	﹤0.01%	811
2017 Q4	$0	Buy	+3	New	+$218	﹤0.01%	917

Other funds holding ATOS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TrueWealth LLC's ATOS Position: Q2 2020 in Review

TrueWealth LLC held its Atossa Therapeutics (ATOS) position steady in Q2 2020 at 3 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #713.

TrueWealth LLC first reported a position in ATOS in Q4 2017 and has held it in 11 quarters since. 13 funds tracked by Wall St. Rank hold ATOS as of Q2 2020.

TrueWealth LLC held 3 shares of Atossa Therapeutics worth $0 as of Q2 2020.
TrueWealth LLC left its Atossa Therapeutics share count unchanged in Q2 2020.
Atossa Therapeutics made up ﹤0.01% of TrueWealth LLC's portfolio in Q2 2020, its #713 holding.
TrueWealth LLC first reported a position in Atossa Therapeutics in Q4 2017 and has held it in 11 quarters since.
13 funds tracked by Wall St. Rank held Atossa Therapeutics as of Q2 2020.

Based on TrueWealth LLC's 13F filing for Q2 2020, filed 15 Jul 2020.